Home > Haematology > Young leukemia survivors face higher-than-average mortality rates for decades

Young leukemia survivors face higher-than-average mortality rates for decades

Journal
Cancer Epidemiology
Reuters Health - 25/05/2022 - Adolescents and young adults (AYA) who survive acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) have shorter lifespans than the general population for up to 30 years after a diagnosis, a registry study suggests. "AYA survivors treated for leukemia are at high risk for early mortality," Dr. Michael Roth of the University of Texas MD Anderson Cancer Center in Houston told Reuters Health by email. "While intensive treatment has led to more cures, this therapy is also likely leading to the development of many chronic serious health conditions later in life." "While cure is still the most important outcome, long-term health and health-related quality of life needs to be strongly considered as we treat patients during and after treatment," he said. "More attention is needed on providing patients access to long-term, high quality survivorship care, regardless of age, sex, race, ethnicity or socioeconomic status." As re...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on